ALBO

Albireo Pharma News

Company Name Stock Ticker Symbol Market Type
Albireo Pharma Inc ALBO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.84 3.66% 23.78 16:47:08
Open Price Low Price High Price Close Price Prev Close
22.70 22.45 24.00 23.78 22.94
more quote information »

Recent News

Date Time Source Heading
11/09/202208:30GLOBEAlbireo to Participate in Jefferies London Healthcare..
11/09/202206:46TRMNWedbush Remains a Buy on Albireo Pharma (ALBO)
11/09/202206:35TRMNH.C. Wainwright Remains a Buy on Albireo Pharma (ALBO)
11/08/202216:33EDGARQuarterly Report (10-q)
11/08/202216:09EDGARCurrent Report Filing (8-k)
11/08/202216:01GLOBEAlbireo Reports Q3 2022 Financial Results and Business..
11/07/202208:30GLOBEBylvay® (odevixibat) Data Presented at AASLD The Liver..
11/03/202211:25TRMNH.C. Wainwright Remains a Buy on Albireo Pharma (ALBO)
11/03/202208:30GLOBEAlbireo Announces 2022 SPARK Grant Winners
11/02/202208:30GLOBEAlbireo Completes Phase 3 BOLD Study Enrollment of..
11/01/202208:30GLOBEAlbireo to Present Late Breaking Bylvay® (odevixibat) Data..
10/31/202208:30GLOBEAlbireo to Report Q3 2022 Financial Results on November 8,..
10/26/202217:55TRMNWedbush Sticks to Their Buy Rating for Albireo Pharma (ALBO)
10/25/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
10/25/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
10/25/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
10/25/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
10/25/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
10/13/202219:38EDGARStatement of Changes in Beneficial Ownership (4)
10/13/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
10/13/202208:30GLOBEAlbireo Presents Data on Greater Efficacy in PFIC..
10/12/202208:30GLOBEAlbireo to Participate in H.C. Wainwright 3rd..
10/11/202209:44TRMNAlbireo Pharma Delivers Promising Phase 3 results in..
10/11/202207:00GLOBEAlbireo Reports Positive Topline Data from Phase 3 Trial of..
10/05/202208:30GLOBEAlbireo to Showcase New Data at AASLD The Liver Meeting®..
10/03/202216:38EDGARStatement of Ownership (sc 13g)
9/27/202216:30GLOBEAlbireo Reports Inducement Grant Under Nasdaq Listing Rule..
9/26/202216:00EDGARStatement of Ownership (sc 13g)
9/22/202212:55TRMNWedbush Sticks to Its Buy Rating for Albireo Pharma (ALBO)
9/22/202210:39TRMNAlbireo Pharma (NASDAQ: ALBO) Shoots Up Post Agreement with..
9/22/202208:36EDGARCurrent Report Filing (8-k)
9/22/202208:30GLOBEAlbireo Announces $115 Million Royalty Monetization..
9/20/202208:00GLOBEAlbireo to Participate in Guggenheim Nantucket Therapeutics..
9/14/202206:45TRMNWedbush Reaffirms Their Buy Rating on Albireo Pharma (ALBO)
9/06/202208:00GLOBEItalian Medicines Agency Approves Reimbursed Access to..
9/01/202208:00GLOBEAlbireo to Participate in Upcoming Investor Conferences
8/25/202217:02EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/22/202217:13GLOBEAlbireo Reports Inducement Grant Under Nasdaq Listing Rule..
8/22/202216:19EDGARAmended Current Report Filing (8-k/a)
8/16/202206:02EDGARCurrent Report Filing (8-k)
8/16/202206:02EDGARSecurities Registration Statement (simplified Form) (s-3)
8/15/202216:34EDGARCurrent Report Filing (8-k)
8/15/202216:05GLOBEAlbireo Reports Q2 2022 Financial Results and Business..
8/10/202217:58EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202217:57EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202217:56EDGARInitial Statement of Beneficial Ownership (3)
8/10/202208:38EDGARCurrent Report Filing (8-k)
8/10/202208:30GLOBEAlbireo Appoints New Members to Board of Directors
8/03/202208:30GLOBEAlbireo to Participate in 2022 Wedbush PacGrow Healthcare..
8/01/202208:30GLOBEAlbireo to Report Q2 2022 Financial Results on August 15,..